Double-blind Comparative Study of TAK-875

NCT01433393 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
192
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda